NEEMA Web Tools
These tools can assist looking at local population sizes, disease trends, and cost projections for a specific jurisdiction.
Predicting future tuberculosis (TB) epidemiology in the United States based on hypothetical scenarios chosen by the user.
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for tuberculosis elimination in the United States: results of a transmission dynamic modelexternal icon. American Journal of Epidemiology. May 2018.
Displaying the state-level amount of “heterogeneity” of tuberculosis incidence for different high-risk populations.
Cherng ST, Shrestha S, Reynolds S, Hill AN, Marks SM, Kelly J, Dowdy DW. Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011–2015external icon. American Journal of Public Health. 2018 Nov;108(S4):S311-4.
Projecting impact of increased targeted testing and treatment on tuberculosis incidence among different high-risk populations in the four states: California, Florida, New York and Texas.
Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM. Impact and Effectiveness of State-level Tuberculosis interventions in California, Florida, New York and Texas: A model-based analysisexternal icon. American Journal of Epidemiology. 2019 Jun 28.
Estimate the number of individuals indicated for PrEP.
Smith DK, Van Handel M, Grey J. Estimates of Persons with Indications for Preexposure Prophylaxis by Jurisdiction Transmission Risk Group, and Race/Ethnicity, United States, 2015external icon. Annals of Epidemiology, 2018.
This Excel-based tool is designed to assist health departments in estimating the short-term impact of behavior change on the burden of sexually transmitted infections among adolescents in their jurisdictions.
The Hep C State Policy Simulator (the Simulator) is a tool to help state heath policy makers and practitioners make decisions regarding policy, strategy, and investments related to hepatitis C. The Simulator was developed by Mass General Hospital and Harvard Medical School with support from CDC through a cooperative agreement awarded to ChangeLab Solutions.
